BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/13/2025 8:55:38 AM | Browse: 43 | Download: 0
Category |
Dermatology |
Manuscript Type |
Case Report |
Article Title |
Diabetic foot ulcer with overlap syndrome: A case report and review of literature
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Shi-Yi Sun, Da-Wei Chen, Jing Wu, Yan Li and Xing-Wu Ran |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
1.3.5 Project for Excellence, West China Hospital of Sichuan University |
No. ZYGD24005 |
1.3.5 Project of Center for High Altitude Medicine, West China Hospital, Sichuan University |
No. GYYX24002 |
Sichuan Science and Technology Program |
No. 2024YFFK0290 |
Health Commission of Sichuan Province |
No. 23LCYJ042 |
Science and Technology Department of Sichuan Province |
No. 2025ZNSFSC1621 |
|
Corresponding Author |
Xing-Wu Ran, Chief Physician, MD, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu 610041, Sichuan Province, China. ranxingwu@163.com |
Key Words |
Diabetic foot ulcer; Overlap syndrome; Anti-synthetase syndrome; Systemic scleroderma; Case report |
Core Tip |
Diabetic foot ulcers (DFUs), although common in diabetes, rarely coexist with connective tissue diseases, particularly overlap syndromes. We describe a unique case involving DFUs with overlap syndrome [systemic sclerosis (SSc) and anti-synthetase syndrome (ASS)]. Literature analysis revealed three key patterns in SSc-related foot ulcers: Low incidence, predominant toe involvement, and rare diabetes comorbidity. No ASS-related foot ulcer cases have been reported. The prognosis of SSc-related foot ulcers is generally favorable, with standard DFU therapies (notably autologous platelet-rich gel) showing efficacy. Bosentan and calcium channel blockers may have therapeutic and preventive effects on SSc-related foot ulcers. |
Citation |
Sun SY, Chen DW, Wu J, Li Y, Ran XW. Diabetic foot ulcer with overlap syndrome: A case report and review of literature. World J Diabetes 2025; In press |
 |
Received |
|
2025-05-19 02:18 |
 |
Peer-Review Started |
|
2025-05-20 00:10 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-06-11 03:48 |
 |
Revised |
|
2025-06-20 01:41 |
 |
Second Decision |
|
2025-07-31 02:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-08-13 08:55 |
 |
Articles in Press |
|
2025-08-13 08:55 |
 |
Publication Fee Transferred |
|
2025-06-24 04:18 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345